PABLO
ROJO CONEJO
Profesor asociado de Ciencias de la Salud
London School of Hygiene & Tropical Medicine
Londres, Reino UnidoPublicaciones en colaboración con investigadores/as de London School of Hygiene & Tropical Medicine (15)
2024
-
Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases
The Pediatric infectious disease journal, Vol. 43, Núm. 5, pp. 444-453
-
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 702-710
2023
-
Adeno-associated virus 2 infection in children with non-A–E hepatitis
Nature, Vol. 617, Núm. 7961, pp. 555-563
-
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change
Journal of Acquired Immune Deficiency Syndromes, Vol. 93, Núm. 1, pp. 42-46
-
Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature
Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 6, pp. 322-331
-
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia
Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 11, pp. 581-585
-
Genomic investigations of unexplained acute hepatitis in children
Nature, Vol. 617, Núm. 7961, pp. 564-573
-
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
The Lancet Child and Adolescent Health, Vol. 7, Núm. 10, pp. 718-727
2022
-
Children living with HIV in Europe: do migrants have worse treatment outcomes?
HIV Medicine, Vol. 23, Núm. 2, pp. 186-196
-
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
The Lancet HIV, Vol. 9, Núm. 9, pp. e627-e637
-
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial
Trials, Vol. 23, Núm. 1
2021
-
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
New England Journal of Medicine, Vol. 385, Núm. 27, pp. 2531-2543
-
Treatment of Multisystem Inflammatory Syndrome in Children
New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22
-
Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients with Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE
Clinical Infectious Diseases, Vol. 73, Núm. 2, pp. 195-202
2019
-
Identification of regulatory variants associated with genetic susceptibility to meningococcal disease
Scientific Reports, Vol. 9, Núm. 1